Annual CFF
-$15.82 M
+$25.99 M+62.16%
December 31, 2024
Summary
- As of March 10, 2025, CTKB annual cash flow from financing activities is -$15.82 million, with the most recent change of +$25.99 million (+62.16%) on December 31, 2024.
- During the last 3 years, CTKB annual CFF has fallen by -$229.38 million (-107.41%).
- CTKB annual CFF is now -107.41% below its all-time high of $213.56 million, reached on December 31, 2021.
Performance
CTKB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$3.64 M
+$8.44 M+69.88%
December 31, 2024
Summary
- As of March 10, 2025, CTKB quarterly cash flow from financing activities is -$3.64 million, with the most recent change of +$8.44 million (+69.88%) on December 31, 2024.
- Over the past year, CTKB quarterly CFF has stayed the same.
- CTKB quarterly CFF is now -101.68% below its all-time high of $217.08 million, reached on September 30, 2021.
Performance
CTKB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$15.82 M
+$30.11 M+65.56%
December 31, 2024
Summary
- As of March 10, 2025, CTKB TTM cash flow from financing activities is -$15.82 million, with the most recent change of +$30.11 million (+65.56%) on December 31, 2024.
- Over the past year, CTKB TTM CFF has stayed the same.
- CTKB TTM CFF is now -104.75% below its all-time high of $333.27 million, reached on September 30, 2021.
Performance
CTKB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CTKB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.2% | 0.0% | 0.0% |
| 3 y3 years | -107.4% | -1785.2% | -474.8% |
| 5 y5 years | -10000.0% | -1785.2% | -474.8% |
CTKB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.4% | +62.2% | -194.6% | +89.2% | -107.2% | +65.6% |
| 5 y | 5-year | -107.4% | +62.2% | -101.7% | +89.2% | -104.8% | +65.6% |
| alltime | all time | -107.4% | +62.2% | -101.7% | +89.2% | -104.8% | +65.6% |
Cytek Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$15.82 M(-62.2%) | -$3.64 M(-69.9%) | -$15.82 M(-65.6%) |
| Sep 2024 | - | -$12.08 M(+606.3%) | -$45.94 M(+9.0%) |
| Jun 2024 | - | -$1.71 M(-206.1%) | -$42.13 M(+4.8%) |
| Mar 2024 | - | $1.61 M(-104.8%) | -$40.20 M(-3.9%) |
| Dec 2023 | -$41.81 M(-858.4%) | -$33.75 M(+308.0%) | -$41.81 M(+893.6%) |
| Sep 2023 | - | -$8.27 M(-3930.6%) | -$4.21 M(-199.7%) |
| Jun 2023 | - | $216.00 K(>+9900.0%) | $4.22 M(-18.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $5.15 M(-6.6%) |
| Dec 2022 | $5.51 M | $3.85 M(+2383.9%) | $5.51 M(+228.2%) |
| Sep 2022 | - | $155.00 K(-86.5%) | $1.68 M(-99.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.14 M(+214.3%) | $218.60 M(+2.3%) |
| Mar 2022 | - | $364.00 K(+2041.2%) | $213.74 M(+0.1%) |
| Dec 2021 | $213.56 M(+74.2%) | $17.00 K(-100.0%) | $213.56 M(-35.9%) |
| Sep 2021 | - | $217.08 M(-5930.7%) | $333.27 M(+189.9%) |
| Jun 2021 | - | -$3.72 M(-2090.9%) | $114.98 M(-6.4%) |
| Mar 2021 | - | $187.00 K(-99.8%) | $122.78 M(+0.1%) |
| Dec 2020 | $122.61 M(>+9900.0%) | $119.73 M(<-9900.0%) | $122.61 M(+4157.2%) |
| Sep 2020 | - | -$1.22 M(-129.8%) | $2.88 M(-29.7%) |
| Jun 2020 | - | $4.08 M(>+9900.0%) | $4.09 M(>+9900.0%) |
| Mar 2020 | - | $13.00 K | $13.00 K |
| Dec 2019 | $93.00 K | - | - |
FAQ
- What is Cytek Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Cytek Biosciences?
- What is Cytek Biosciences annual CFF year-on-year change?
- What is Cytek Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cytek Biosciences?
- What is Cytek Biosciences quarterly CFF year-on-year change?
- What is Cytek Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cytek Biosciences?
- What is Cytek Biosciences TTM CFF year-on-year change?
What is Cytek Biosciences annual cash flow from financing activities?
The current annual CFF of CTKB is -$15.82 M
What is the all time high annual CFF for Cytek Biosciences?
Cytek Biosciences all-time high annual cash flow from financing activities is $213.56 M
What is Cytek Biosciences annual CFF year-on-year change?
Over the past year, CTKB annual cash flow from financing activities has changed by +$25.99 M (+62.16%)
What is Cytek Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of CTKB is -$3.64 M
What is the all time high quarterly CFF for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash flow from financing activities is $217.08 M
What is Cytek Biosciences quarterly CFF year-on-year change?
Over the past year, CTKB quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Cytek Biosciences TTM cash flow from financing activities?
The current TTM CFF of CTKB is -$15.82 M
What is the all time high TTM CFF for Cytek Biosciences?
Cytek Biosciences all-time high TTM cash flow from financing activities is $333.27 M
What is Cytek Biosciences TTM CFF year-on-year change?
Over the past year, CTKB TTM cash flow from financing activities has changed by $0.00 (0.00%)